Silo Wellness (XCNQ:SILO) Change In Receivables : C$0.00 Mil (TTM As of Jul. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Silo Wellness Change In Receivables?

Silo Wellness's change in receivables for the quarter that ended in Jul. 2023 was C$0.00 Mil. It means Silo Wellness's Accounts Receivable stayed the same from Apr. 2023 to Jul. 2023 .

Silo Wellness's change in receivables for the fiscal year that ended in Oct. 2022 was C$0.49 Mil. It means Silo Wellness's Accounts Receivable declined by C$0.49 Mil from Oct. 2021 to Oct. 2022 .

Silo Wellness's Accounts Receivable for the quarter that ended in Jul. 2023 was C$0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Silo Wellness's Days Sales Outstanding for the three months ended in Jul. 2023 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Silo Wellness's liquidation value for the three months ended in Jul. 2023 was C$-2.41 Mil.

Silo Wellness Change In Receivables Historical Data

The historical data trend for Silo Wellness's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Silo Wellness Change In Receivables Chart

Silo Wellness Annual Data

Trend

Oct20

Oct21

Oct22

Change In Receivables

-0.34

0.49

Silo Wellness Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
Change In Receivables	Get a 7-Day Free Trial										-	-	-	-	-

Silo Wellness Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jul. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Silo Wellness (XCNQ:SILO) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Silo Wellness's Days Sales Outstanding for the quarter that ended in Jul. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0.095	*	91
=	0.00

2. In Ben Graham's calculation of liquidation value, Silo Wellness's accounts receivable are only considered to be worth 75% of book value:

Silo Wellness's liquidation value for the quarter that ended in Jul. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0	-	2.414	+	0.75 * 0	+	0.5 * 0
=	-2.41

Silo Wellness Change In Receivables Related Terms

Thank you for viewing the detailed overview of Silo Wellness's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Silo Wellness (XCNQ:SILO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Silo Wellness Inc (XCNQ:SILO) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Consumers Road, Suite 702, Toronto, ON, CAN, M2J 4R4

Website

https://www.silowellness.com

Silo Wellness Inc operates psychedelic clinics and develops legal functional mushroom consumer products. It is focused on health and wellness by developing and introducing psychedelic medicine to reduce trauma and increase performance by destigmatizing the active compounds in psychedelics and innovating ease of administration and ingestion.

Executives

Michael Hartman

Director